最新更新 :
28/04/2024
全麻醉药   Thiopental sodium  
注射液
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF
   化学式  

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Anapental 埃及
Anental 哥伦比亚, 委内瑞拉
Epental 沙特阿拉伯
Exipental 伊朗
Farmotal 意大利
Gabapentax 哥伦比亚
Hipnopento 阿根廷
Nesdonal 荷兰
Pantul 厄瓜多尔, 秘鲁
Pensodital 墨西哥
Pental 土耳其
Pentarim 墨西哥
Pentax 委内瑞拉
Pentocur 冰岛, 挪威
Pentotex 马来西亚
Pentothal 丹麦, 加拿大, 卢森堡, 墨西哥, 希腊, 意大利, 比利时, 澳大利亚, 瑞典, 瑞士, 芬兰
Sodipental 哥伦比亚, 墨西哥
Thiojex 智利
Thiomek 秘鲁
Thiopental 伊朗, 匈牙利, 埃及, 奥地利, 希腊, 德国, 摩洛哥, 沙特阿拉伯, 法国, 波兰, 爱尔兰, 突尼斯, 罗马尼亚, 英国, 马来西亚
Thiopentax 厄瓜多尔, 委内瑞拉
Tiobarbital 哥伦比亚, 西班牙
Trapanal 德国
Zedisol 墨西哥
引用文献   注射液   引用文献 : Thiopental sodium  
种类 出版物
59 文献 Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125 文献 Chernin EL, Stewart JT, Smiler B.
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C.
Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126 文献 Prankerd RJ, Jones RD.
Physicochemical compatibility of propofol with thiopental sodium.
Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299 文献 Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314 文献 Chiu MF, Schwartz ML.
Visual compatibility of injectable drugs used in the intensive care unit.
Am J Health-Syst Pharm 1997 ; 54: 64-65.
319 文献 Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
350 文献 Martens HJ, De Goede PN, Van Loenen AC.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Am J Hosp Pharm 1990 ; 47: 369-373.
527 文献 Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.
Chemical stability of thiopental sodium injection in disposable plastic syringes.
J Clin Pharm Ther 1987 ; 12: 339-342.
642 文献 Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
Norepinephrine stability in saline solutions.
Hosp Pharm 1988 ; 23: 44,49, 59.
755 实验室 Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
MSD France 2016
871 文献 Haws JL, Herman N, Clark Y, Bjoraker R, Jones D.
The chemical stability and sterility of sodium thiopental after preparation.
Anesth Analg 1998 ; 86: 208-213.
919 文献 Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Anesth Analg 1998 ; 86: 422-426.
1173 文献 Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.
Interactions between drugs and polyvinyl chloride infusion bags.
Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713 文献 Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721 文献 Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1803 文献 Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073 文献 Taniguchi T, Yamamoto K, Kobayashi T.
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Can J Anesth 1998 ; 45: 347-351.
2079 文献 Morton WD, Lerman J.
The effect of pancuronium on the solubility of aqueous thiopentone.
Can J Anesth 1987 ; 34: 87-89.
2090 文献 Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2105 文献 Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Farm Hosp 1999 ; 23: 357-360.
2146 文献 Trissel LA, Xu QA, Baker M.
Drug compatibility with new polyolefin infusion solution containers.
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231 文献 de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134 文献 Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
Enferm Intensiva 2010 ; 21: 96-103.
3212 文献 Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Enferm Intensiva 2011 ;22:78-82.
3372 文献 Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373 文献 Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3377 文献 Huddy NC, Durcan JJ.
Precipitation betwen meptazinol and thiopentone.
Anaesthesia 1983 ; 38: 601-602.
3408 文献 Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3464 文献 Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.
Compatibilidad física de la amiodarona en perfusión continua
Enferm Clin 2011 21:25-29.
3466 文献 B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
Enferm Intensiva 2011 ;22:78-82.
3501 实验室 Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
Pfizer 2011
3503 实验室 Fentanyl - Summary of product Characteristics
Hameln Pharmaceuticals 2012
3525 实验室 Pethidine hydrochloride - Summary of product Characteristics
AMCO Amdipharm Mercury 2012
3526 实验室 Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3531 实验室 Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
Wockhardt 2014
3549 实验室 Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3564 实验室 Rocuronium B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3599 实验室 Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
Amco Amdipharm Mercry 2013
3600 实验室 Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
UCB Pharma SA 2009
3601 实验室 Cisatracurium Actavis - Résumé des Caractéristiques du Produit
Actavis 2012
3607 实验室 Esmolol hydrochloride for injection - Summary of Product Characteristics
AOP Orphan Pharmaceuticals AG 2013
3612 实验室 Doxapram (Dopram) - Summary of Product Characteristics
Amdipharm Mercury Company 2012
3614 实验室 Nicardipine Injection - Summary of Product Characteristics
American Regent Inc 2013
3629 实验室 Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
Actavis UK 2014
3630 实验室 Vecuronium (Norcuron®) - Summary of Product Characteristics
Merck Sharp Dohme 2012
3631 实验室 Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3674 实验室 Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3675 实验室 Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3676 实验室 Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014
3767 文献 Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Pharmactuel 2014 ; 47, 3 : 167-172.
3823 文献 Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3932 实验室 Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
3941 实验室 Nicardipine - Summary of Product Characteristics
Concordia International 2017
4009 实验室
Droperidol - Résumé des Caractéristiques du Produit
Panpharma 2017
4428 文献 Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700 实验室 Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
AS Kalceks 2022

  Mentions Légales